The US has authorised Covid-19 booster doses that target the highly contagious Omicron variant in the hopes of preventing another winter surge in cases.
The move on Wednesday by the Food and Drug Administration (FDA) to approve the shots from Pfizer and Moderna means they could become available to the public within days.
